Abstract
Liver failure is associated with a neuropsychiatric syndrome, known as hepatic encephalopathy (HE). Finasteride, inhibitor of neurosteroid synthesis, may improve the course of HE. The aim of our study was to investigate the influence of finasteride on mean and relative power density of EEG bands, determined by spectral analysis, in rat model of thioacetamide-induced HE. Male Wistar rats were divided into groups: (1) control; (2) thioacetamide-treated group, TAA (900 mg/kg); (3) finasteride-treated group, FIN (150 mg/kg); and (4) group treated with finasteride (150 mg/kg) and thioacetamide (900 mg/kg), FIN + TAA. Daily doses of FIN (50 mg/kg) and TAA (300 mg/kg) were administered during 3 subsequent days, and in FIN + TAA group FIN was administered 2 h before every dose of TAA. EEG was recorded 22–24 h after treatment and analyzed by fast Fourier transformation. While TAA did not induce significant changes in the beta band, mean and relative power in this band were significantly higher in FIN + TAA versus control group (p < 0.01). TAA caused a significant decline in mean power in alpha, theta, and delta band, and in FIN + TAA group the mean power in these bands was significantly higher compared with control. While in TAA group relative power was significantly decreased in theta (p < 0.01) and increased in delta band (p < 0.01) versus control, the opposite changes were found in FIN + TAA group: an increase in theta (p < 0.01) and a decrease in delta relative power (p < 0.01). In this study, finasteride pretreatment caused EEG changes that correspond to mild TAA-induced HE.
Similar content being viewed by others
References
Ahboucha S (2011) Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms. Curr Mol Pharmacol 4:1–13
Ahboucha S, Butterworth RF (2008) The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Inter 52:575–587
Ahboucha S, Desjardins P, Chatauret N, Pomier-Layrargues G, Butterworth RF (2003) Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy. Neurochem Inter 43:551–556
Ahboucha S, Talani G, Fanutza T, Sanna E, Biggio G, Gamrani H, Butterworth RF (2012) Reduced brain levels of DHEAS in hepatic coma patients: significance for increased GABAergic tone in hepatic encephalopathy. Neurochem Inter 61:48–53
Amodio P, Montagnese S (2015) Clinical neurophysiology of hepatic encephalopathy. J Clin Exp Hepatol 5(Suppl 1):S60–S68
Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A (2001) Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 35:37–45
Bickford RG, Butt HR (1955) Hepatic coma: the electroencephalographic pattern. J Clin Invest 34:790–799
Butterworth RF (1998) Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy. Metab Brain Dis 13:337–349
Butterworth RF (2013) The liver-brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol 10:522–528
Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B, el Mlili N, Boix J, Agusti A, Felipo V (2009) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis 24:69–80
ElMlili N, Boix J, Ahabrach H, Rodrigo R, Errami M, Felipo V (2010) Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum. J Neurochem 112:1005–1114
Ficker DM, Westmoreland BF, Sharbrough FW (1997) Epileptiform abnormalities in hepatic encephalopathy. J Clin Neurophysiol 14:230–234
Finn DA, Ford MM, Wiren KM, Roselli CE, Crabbe JC (2004) The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol Ther 101:91–112
Ford MM, Nickel JD, Finn DA (2005) Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids? Alcohol 37:23–33
Gomides LF, Marques PE, Faleiros BE, Pereira RV, Amaral SS, Lage TR, Resende GH, Guidine PA, Foureaux G, Ribeiro FM, Martins FP, Fontes MA, Ferreira AJ, Russo RC, Teixeira MM, Moraes MF, Teixeira AL, Menezes GB (2014) Murine model to study brain, behavior and immunity during hepatic encephalopathy. World J Hepatol 6:243–250
Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P, Members of the ISHEN commission on Neurophysiological Investigations (2009) Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29:789–796
Hrncić D, Rasić-Marković A, Krstić D, Macut D, Djuric D, Stanojlović O (2010) The role of nitric oxide in homocysteine thiolactone-induced seizures in adult rats. Cell Mol Neurobiol 30:219–231
Ikeda A, Klem GH, Lüders HO (2003) Metabolic, infectious, and hereditary encephalopathies. In: Ebersole J, Pedley TA (eds) Current practice of clinical electroencephalography. Lippincott Williams & Wilkins, Philadelphia, pp 348–377
Kullmann F, Hollerbach S, Lock G, Holstege A, Dierks T, Schölmerich J (2001) Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease. Eur J Gastroenterol Hepatol 13:513–522
Ladurelle N, Eychenne B, Denton D, Blair-West J, Schumacher M, Robel P, Baulieu E (2000) Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res 858:371–379
Mans AM, Kukulka KM, McAvoy KJ, Rokosz NC (1992) Regional distribution and kinetics of three sites on the GABAA receptor: lack of effect of portacaval shunting. J Cereb Blood Flow Metab 12:334–346
Martino ME, Fernández-Lorente J, Romero-Vives M, Bárcena R, Gaztelu JM (2014) Brain oscillatory activity during sleep shows unknown dysfunctions in early encephalopathy. J Physiol Biochem 70:821–835
Mladenovic D, Hrncic D, Rasic-Markovic A, Puskas N, Petrovich S, Stanojlovic O (2013) Spectral analysis of thioacetamide-induced electroencephalographic changes in rats. Hum Exp Toxicol 32:90–100
Mladenović D, Krstić D, Čolović M, Radosavljević T, Rašić-Marković A, Hrnčić D, Macut D, Stanojlović O (2012a) Different sensitivity of various brain structures to thioacetamide-induced lipid peroxidation. Med Chem 8:52–58
Mladenović D, Radosavljević T, Hrnčić D, Rašić-Marković A, Puškaš N, Maksić N, Djuric D, Stanojlović O (2012b) Behavioral and electroencephalographic manifestations of thioacetamide-induced encephalopathy in rats. Can J Physiol Pharmacol 90:1219–1227
Mladenović D, Hrnčić D, Petronijević N, Jevtić G, Radosavljević T, Rašić-Marković A, Puškaš N, Maksić N, Stanojlović O (2014) Finasteride improves motor, EEG, and cellular changes in rat brain in thioacetamide-induced hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 307:G931–G940
Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, Cillo U, Bombonato G, Bolognesi M, Sacerdoti D, Gatta A, Merkel C, Amodio P (2014) Covert hepatic encephalopathy: agreement and predictive validity of different indices. World J Gastroenterol 20:15756–15762
Müller-Preuss P, Rupprecht R, Lancel M (2002) The effects of the neuroactive steroid 3 alpha, 5 alpha-THDOC on sleep in the rat. NeuroReport 13:487–490
Palomero-Gallagher N, Bidmon HJ, Cremer M, Schleicher A, Kircheis G, Reifenberger G, Kostopoulos G, Häussinger D, Zilles K (2009) Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy. Cell Physiol Biochem 24:291–306
Rothstein JD, McKhann G, Guarneri P, Barbaccia ML, Guidotti A, Costa E (1989) Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy. Ann Neurol 26:57–62
Sagalés T, Gimeno V, de la Calzada MD, Casellas F, Dolors Macià M, Villar Soriano M (1990) Brain mapping analysis in patients with hepatic encephalopathy. Brain Topogr 2:221–228
Skowrońska M, Albrecht J (2013) Oxidative and nitrosative stress in ammonia neurotoxicity. Neurochem Inter 62:731–737
Stanojlović O, Rasić-Marković A, Hrncić D, Susić V, Macut D, Radosavljević T, Djuric D (2009) Two types of seizures in homocysteine thiolactone-treated adult rats, behavioral and electroencephalographic study. Cell Mol Neurobiol 29:329–339
Stewart J, Särkelä M, Koivusalo AM, Wennervirta J, Salmi T, Isoniemi H, Stenman UH, Viertiö-Oja H, Lapinlampi P, Lindgren L, Salminen US, Vakkuri A (2014) Frontal electroencephalogram variables are associated with the outcome and stage of hepatic encephalopathy in acute liver failure. Liver Transpl 20:1256–1265
Yao H, Sadoshima S, Fujii K, Kusada K, Ishitsuka T, Tamaki K, Fujishima M (1987) Cerebrospinal fluid lactate in patients with hepatic encephalopathy. Eur Neurol 27:182–187
Acknowledgments
This work was supported by the Ministry of Education, Science and Technological Development of Serbia, Grant No 175032.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mladenović, D., Hrnčić, D., Rašić-Marković, A. et al. The Influence of Finasteride on Mean and Relative Spectral Density of EEG Bands in Rat Model of Thioacetamide-Induced Hepatic Encephalopathy. Neurotox Res 30, 150–158 (2016). https://doi.org/10.1007/s12640-016-9610-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-016-9610-z